The BCAA/Tyrosine Ratio (BTR) is also supported as a metric for the risk and advancement of liver disease [37], while decreased tyrosine is associated with poorer survival outcomes of HCC [38]. This evidence concerns the gene ARID4B and hepatocellular carcinoma.